
¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín
Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.
Vendaje para proteger las vísceras abdominales en terapia de presión negativa
Resumen
Tipo:
Oferta Tecnológica
Referencia:
TOES20180831001
Publicado:
11/10/2018
Caducidad:
12/10/2019
Resumen:
Un instituto de investigación biomédica español ha desarrollado un vendaje para proteger las vísceras abdominales en la terapia de presión negativa que evita la adhesión a los tejidos de los órganos internos de la pared abdominal y optimiza la capacidad de drenaje y distribución de la terapia de presión negativa. El instituto, que ha desarrollado y probado un prototipo en un modelo porcino, busca empresas interesadas en comercializar este vendaje y establecer acuerdos de servicio o cooperación en materia de investigación para su desarrollo.
Details
Tittle:
A wound dressing for abdominal viscera protection in negative-pressure wound therapy
Summary:
A Spanish Biomedical Research Institute has developed a wound dressing for abdominal viscera protection in negative-pressure wound therapy that prevents adhesion to the internal organs tissues of the abdominal wall and optimizes the drainage capacity and distribution of negative pressure therapy.
The Institute would like to talk to companies interested in commercializing this wound dressing, a services agreement or in a research cooperation agreement to develop it.
The Institute would like to talk to companies interested in commercializing this wound dressing, a services agreement or in a research cooperation agreement to develop it.
Description:
A Spanish Biomedical Research Institute has developed a wound dressing for abdominal viscera protection in negative-pressure wound therapy that prevents adhesion to the internal organs tissues of the abdominal wall and optimizes the drainage capacity and distribution of negative pressure therapy.
Abdominal compartment syndrome is caused by intra-abdominal hypertension (IAH), leading to ischemia and organ dysfunction. When abdominal compartment syndrome (ACS) occurs, it is necessary to establish a system for the management of wounds that facilitates the re-entry into the abdominal cavity and allows successive interventions.
Negative pressure therapy (TPN) mitigates intra-abdominal hypertension (IAH) and prevent its progression to abdominal compartment syndrome (ACS), facilitating the healing and closing of the abdominal cavity.
Here the Research Institute presents a wound dressing for abdominal viscera protection in negative-pressure wound therapy (TPN) that prevents adhesion to the internal organs tissues of the abdominal wall and optimizes the drainage capacity and distribution of negative pressure therapy.
The Institution would like to talk to companies interested in commercializing this wound dressing, a services agreement or in a research cooperation agreement to develop it.
The present technology is available to license.
Abdominal compartment syndrome is caused by intra-abdominal hypertension (IAH), leading to ischemia and organ dysfunction. When abdominal compartment syndrome (ACS) occurs, it is necessary to establish a system for the management of wounds that facilitates the re-entry into the abdominal cavity and allows successive interventions.
Negative pressure therapy (TPN) mitigates intra-abdominal hypertension (IAH) and prevent its progression to abdominal compartment syndrome (ACS), facilitating the healing and closing of the abdominal cavity.
Here the Research Institute presents a wound dressing for abdominal viscera protection in negative-pressure wound therapy (TPN) that prevents adhesion to the internal organs tissues of the abdominal wall and optimizes the drainage capacity and distribution of negative pressure therapy.
The Institution would like to talk to companies interested in commercializing this wound dressing, a services agreement or in a research cooperation agreement to develop it.
The present technology is available to license.
Advantages and Innovations:
The main competitive advantages of the wound dressing are:
- It avoids its adherence on the tissues, allowing the effluents of the internal organs to drain homogeneously.
- It optimizes the distribution of the negative pressure therapy by the wound dressing surface to the most distal areas, improving the drainage capacity.
- It avoids its adherence on the tissues, allowing the effluents of the internal organs to drain homogeneously.
- It optimizes the distribution of the negative pressure therapy by the wound dressing surface to the most distal areas, improving the drainage capacity.
Stage of Development:
Prototype available for demonstration
IPs:
Patent(s) applied for but not yet granted
CommeR Statunts Regarding IPR Status:
A Spanish utility model application covering this product was filed on 8th june, 2018.
Partner sought
Type and Role of Partner Sought:
Companies involved in the development of devices for negative pressure therapy (TPN) as well as dressings wounds and drainage components of said systems.
Client
Type and Size of Client:
R&D Institution
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
French
Spanish
French
Spanish
Keywords
Technology Keywords:
06001017 Cirugía
06001013 Tecnología médica / ingeniería biomédica
06001013 Tecnología médica / ingeniería biomédica